Form 4: J&J Executive Vests 4,378 Performance Share Units

Johnson & Johnson EVP Timothy Schmid's performance-based share units convert to common stock, reflecting achievement of award conditions.

Summary

• Timothy Schmid, EVP, WW Chair, MedTech at Johnson & Johnson (JNJ), acquired 4,378 Performance Share Units (PSUs).
• The PSUs were awarded under the Issuer's Long-Term Incentive Plan on February 13, 2023.
• The transaction date for the acquisition was February 9, 2026, which is when the performance conditions were certified.
• These PSUs convert into shares of Common Stock upon vesting.
• The number of PSUs reflects the target number originally granted, adjusted for achievement relative to the performance conditions.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a positive indicator of management's alignment with shareholder interests through performance-based compensation and successful achievement of targets, reflecting good corporate governance practices.

Positives

• The vesting of Performance Share Units indicates that the executive, Timothy Schmid, successfully met the performance conditions set forth in the award agreement, aligning management incentives with company performance.
• This transaction increases the executive's direct beneficial ownership in Johnson & Johnson, signaling continued alignment of interests with shareholders.

Negatives

• The conversion of PSUs to common stock, while performance-based, represents a minor dilution to existing shareholders as new shares are issued.

Future Outlook

The Performance Share Units are expected to convert into shares of Johnson & Johnson Common Stock upon their vesting, further aligning the executive's long-term interests with the company's performance.

Industry Context

StockSavvy.ai notes that performance-based equity awards, such as Performance Share Units, are a standard component of executive compensation across the pharmaceutical and medical technology industries. This practice aims to incentivize long-term strategic execution and align management's financial interests with shareholder value creation.

Comparison to Industry Standards

• StockSavvy.ai notes that performance-based equity awards, such as Performance Share Units (PSUs), are a standard component of executive compensation packages across the S&P 500, particularly within the healthcare and technology sectors.
• Companies like Pfizer, Medtronic, and Abbott Laboratories frequently utilize similar long-term incentive plans to align executive performance with shareholder value creation, often tying vesting to financial metrics like revenue growth, EPS, or total shareholder return over multi-year periods.
• This specific vesting event for Timothy Schmid is consistent with such industry-wide practices designed to incentivize long-term strategic execution and reward the achievement of pre-defined corporate objectives.

Stakeholder Impact

• Shareholders: Minor dilution from the issuance of new shares, but also increased alignment of executive interests with long-term company performance.
• Employees: Reinforces the company's commitment to performance-based compensation structures for key executives.

Next Steps

• The Performance Share Units will convert into shares of Johnson & Johnson Common Stock upon their vesting.

Key Dates

Keywords

Johnson & Johnson, JNJ, Performance Share Units, PSUs, Executive Compensation, Insider Transaction, SEC Form 4, Equity Award, MedTech